APA (7th ed.) Citation

DI, B., C, Z., H, T., FH, F., & MH, R. (2026). Initial Real-World Evidence for Lecanemab in the United States. Drugs & aging, 43(1), 69. https://doi.org/10.1007/s40266-025-01261-x

Chicago Style (17th ed.) Citation

DI, Brixner, Zhao C, Toyosaki H, Frech FH, and Rosenbloom MH. "Initial Real-World Evidence for Lecanemab in the United States." Drugs & Aging 43, no. 1 (2026): 69. https://doi.org/10.1007/s40266-025-01261-x.

MLA (9th ed.) Citation

DI, Brixner, et al. "Initial Real-World Evidence for Lecanemab in the United States." Drugs & Aging, vol. 43, no. 1, 2026, p. 69, https://doi.org/10.1007/s40266-025-01261-x.